InvestorsHub Logo
Followers 6
Posts 1678
Boards Moderated 0
Alias Born 04/15/2005

Re: None

Saturday, 05/13/2017 12:07:16 AM

Saturday, May 13, 2017 12:07:16 AM

Post# of 73611
Am I missing something

This is from page 7 of the annual report on 4/19/2017

They paid Dr. Phillips for the technology and then upgraded it and have provisional patents

On January 31, 2014, the Company purchased an exclusive license (the "License") on the patent pending
technology from Dr. Howard Phillips represented by US Patent application #20130190274. The Company
amended the License on January 20, 2017 such that it is now a non-exclusive distribution and licensing agreement.
Apart from the technology licensed from Dr. Howard Phillips, the Company is currently using a second generation
transdermal technology to manufacture and develop its products. This technology was exclusively
licensed from a related party. During 2016, provisional patents were been filed on this technology. The Company
received provisional patent #62433964 ‘AQUEOUS TOPICAL SOLUTIONS for this technology. The Company
believes the newer technology has additional benefits and plans to incorporate this topical delivery system into
most, if not all of its future products.